...
首页> 外文期刊>Genes and Development: a Journal Devoted to the Molecular Analysis of Gene Expression in Eukaryotes, Prokaryotes, and Viruses >Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene.
【24h】

Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene.

机译:缺乏c-Myc基因的皮肤表皮对Ras驱动的肿瘤发生具有抵抗力,但在p21Cip1基因进一步丢失后可以重新获得敏感性。

获取原文
获取原文并翻译 | 示例
           

摘要

The target gene(s) required for Myc-mediated tumorigenesis are still elusive. Here we show that while endogenous c-Myc is surprisingly dispensable for skin homeostasis and TPA-induced hyperplasia, c-Myc-deficient epidermis is resistant to Ras-mediated DMBA/TPAinduced tumorigenesis. This is mechanistically linked to p21(Cip1), which is induced in tumors by the activated Ras-ERK pathway but repressed by c-Myc. Acute elimination of c-Myc in established tumors leads to the up-regulation of p21(Cip1), and epidermis lacking both p21(Cip1) and c-Myc reacquires normal sensitivity to DMBA/TPA-induced tumorigenesis. This identifies c-Myc-mediated repression of p21(Cip1) as a key step for Ras-driven epidermal tumorigenesis.
机译:Myc介导的肿瘤发生所需的靶基因仍然难以捉摸。在这里,我们显示,尽管内源性c-Myc对于皮肤稳态和TPA诱导的增生而言是令人惊讶地可有可无,但c-Myc缺失的表皮却对Ras介导的DMBA / TPA诱导的肿瘤发生具有抵抗力。这在机械上与p21(Cip1)相关,p21(Cip1)通过激活的Ras-ERK途径在肿瘤中诱导,但被c-Myc抑制。急性消除已建立的肿瘤中的c-Myc会导致p21(Cip1)的上调,而缺乏p21(Cip1)和c-Myc的表皮则需要DMBA / TPA诱导的肿瘤发生的正常敏感性。这确定了c-Myc介导的p21(Cip1)抑制是Ras驱动的表皮肿瘤发生的关键步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号